SCHEMBL845331

SCHEMBL845331

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C=CCN3C(=O)C3CCC3)cc2)cc1)[C@@H]1C=CCN1C(=O)C1CCC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.41
NAMPT P43490 1/20 0.38
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 4/20 0.37
HTT P42858 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 2/20 0.37
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 2/20 0.36
ALOX15 P16050 1/20 0.36
ESR2 Q92731 1/20 0.36
PTPN2 P17706 1/20 0.36
RAB9A P51151 1/20 0.35
CNR2 P34972 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872031 0.90 PTPN1 (0.34) PTPN1NAMPTALDH1A1KDM4EHTT
SCHEMBL845097 0.83 NAMPT (0.39) NAMPTALDH1A1KDM4EHTTMEN1
SCHEMBL845214 0.81 ITGB1 (0.39) NAMPTALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL845328 0.79 NAMPT (0.35) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL845255 0.78 CYP2C9 (0.47) PTPN1ALDH1A1HTTMEN1KMT2A
SCHEMBL844741 0.77 ITGB1 (0.39) NAMPTKDM4EMEN1KMT2ALMNA
SCHEMBL12490796 0.77 PTPN1 (0.41) PTPN1ALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL13272184 0.74 PDE3B (0.34) NAMPTMEN1KMT2AMAPTRAB9A
SCHEMBL845099 0.74 ITGB1 (0.44) ALDH1A1KDM4EHTTKMT2ALMNA
SCHEMBL844884 0.73 HTT (0.48) ALDH1A1HTTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed